Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/16588| Title: | Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand | Austin Authors: | Trubiano, Jason ;Cheng, AC;Korman, TM;Roder, C;Campbell, A ;May, MLA;Blyth, CC;Ferguson, JK;Blackmore, TK;Riley, TV;Athan, E | Affiliation: | Austin Health, Heidelberg, Victoria, Australia Infectious Diseases Infectious Diseases Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia Infectious Diseases Department, Alfred Health, Melbourne, Victoria, Australia Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia Infection Prevention and Healthcare Epidemiology Unit, Alfred Hospital, Melbourne, Victoria, Australia Monash Infectious Diseases, Monash Health, Monash University, Melbourne, Victoria, Australia School of Medicine, Deakin University, Geelong, Victoria, Australia Geelong Centre for Emerging Infectious Diseases, Barwon Health, Geelong, Victoria, Australia Infectious Diseases Department, Princess Margaret Hospital for Children, Queen Elizabeth II Medical Centre, Perth, Western Australia, Australia Infection Management and Prevention Service, Lady Cilento Children's Hospital, Brisbane, Queensland, Australia Sullivan Nicolaides Pathology, Brisbane, Queensland, Australia School of Paediatrics and Child Health, The University of Western Australia, Queen Elizabeth II Medical Centre, Perth, Western Australia, Australia Department of Microbiology, PathWest Laboratory Medicine, Princess Margaret Hospital, Queen Elizabeth II Medical Centre, Perth, Western Australia, Australia Pathology North, NSW Pathology, Wellington South, New Zealand Immunology and Infectious Diseases Unit, John Hunter Hospital, Wellington South, New Zealand Universities of New England and Newcastle, Newcastle, New South Wales, Australia Laboratory Services, Wellington Regional Hospital, Wellington South, New Zealand Microbiology and Immunology, School of Pathology and Laboratory Medicine, The University of Western Australia, Queen Elizabeth II Medical Centre, Perth, Western Australia, Australia Department of Microbiology, PathWest Laboratory Medicine, Queen Elizabeth II Medical Centre, Perth, Western Australia, Australia Department of Infectious Disease, Barwon Health, Geelong, Victoria, Australia |
Issue Date: | Apr-2016 | Publication information: | Internal Medicine Journal 2016; 46(4): 479-493 | Abstract: | The incidence of Clostridium difficile infection (CDI) continues to rise, whilst treatment remains problematic due to recurrent, refractory and potentially severe nature of disease. The treatment of C. difficile is a challenge for community and hospital-based clinicians. With the advent of an expanding therapeutic arsenal against C. difficile since the last published Australasian guidelines, an update on CDI treatment recommendations for Australasian clinicians was required. On behalf of the Australasian Society of Infectious Diseases, we present the updated guidelines for the management of CDI in adults and children. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/16588 | DOI: | 10.1111/imj.13027 | ORCID: | Journal: | Internal Medicine Journal | PubMed URL: | https://pubmed.ncbi.nlm.nih.gov/27062204 | Type: | Journal Article | Subjects: | Clostridium difficile Faecal microbiota transplant (FMT) Fidaxomicin Metronidazole Treatment Vancomycin |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.